feasibility of implant placement in patients with osteonecrosis of the jaw using a new surface-treated implant: a single-group prospective exploratory clinical trial

Ewha Womans University Medical Center0 个研究点目标入组 20 人开始时间: 待定最近更新: 2024年8月19日

试验速览

暂无简介。

•? Adult patients whose age is over 19 years of age and whose jaw growth has been completed
•? If you have or have been given a medication that can cause jaw necrosis:IV Bisphosphonate, Denosumab, Angiogenesis inhibitor, etc.Oral use for more than 2 years have been diagnosed with osteonecrosis of the jaw amd have undergone bone resection surgery, then 6 months after complete recovery
•? Patients who agreed to participate in the clinical trial and signed the patient consent form

•? If there is a history of radiation therapy in the head and neck, including jaw, or a malignant tumor of the jaw area
•? Patients who unctrolled systemic disease, including hemorrhagic diseases
•? Patients who have hypersensitivity to implant, metal plate materials, or implant materials
•? Patients requiring extensive bone grafting
•? Patients who have severe oral and jaw habits(bruxism, clenching)
•? If the investigator determines that participation in the clinical trial is inappropriate because it may affect other ethical or clinical trial results.
•? Patients who find implant placement surgery difficult (uncooperative patients, cases with very poor oral hygiene management, etc.)
•? Patients who do not understand the purpose of the research and do not agree

发起方